ECG Sensor Patches Market worth $2.32 billion by 2032 with 12.0% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., July 17, 2025 /PRNewswire/ -- The global ECG Sensor Patches Market, valued at US$0.95 billion in 2024 stood at US$1.05 billion in 2025 and is projected to advance at a resilient CAGR of 12.0% from 2025 to 2032, culminating in a forecasted valuation of US$2.32 billion by the end of the period. The growth is mainly attributed to the rising target patient population and increasing cases of CVD. Rising technological developments in wireless monitoring and wearable healthcare products are also expected to fuel market growth. The growing focus on mHealth apps, connected devices, and wearable tech is expected to fuel continuous advancements in cardiac monitoring, thereby increasing efficiency. Industry stakeholders are also focused on forging strategic partnerships and introducing new products to strengthen their market position.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=179350490
Browse in-depth TOC on "ECG Sensor Patches Market"
270 - Tables
57 - Figures
270 - Pages
By lead type, the single-lead ECG Sensor Patch segment accounted for the largest market share in 2024 due to its high clinical utility in ambulatory cardiac rhythm tracking, particularly for arrhythmia and post-operative monitoring. These patches are favored in outpatient and home settings because they are lightweight, unobtrusive, and offer sufficient diagnostic accuracy for primary care workflows. Their fast deployment in large-scale screening programs and emergency medical settings—especially for atrial fibrillation and ischemic events—gives them a distinct edge over multi-lead systems, which are typically bulkier and costlier. Additionally, reimbursement policies in key markets support single-lead ambulatory ECG monitoring, especially with AI-based rhythm interpretation, driving rapid adoption across primary and preventive care models.
By product, the disposable ECG sensor patch segment is expected to grow at the highest CAGR during the forecast period due to rising concerns about infection control, especially in post-pandemic healthcare environments. These patches eliminate the need for reprocessing and reduce the risk of cross-contamination in both acute care and outpatient settings. Their use is expanding rapidly in outpatient telemetry and during clinical trials for cardiac safety assessments, where cost-effective, single-use patches streamline logistics. Furthermore, recent advancements in flexible printed electronics have reduced manufacturing costs while enhancing patch adhesion and signal quality. Payers and providers also increasingly favour disposable options in value-based care settings to simplify workflows and reduce device turnaround time.
By geography, North America accounted for the largest share of the market in 2024 owing to the region's early integration of digital cardiac monitoring in clinical pathways, especially for heart failure and post-stroke management. The US FDA's expedited pathways for wearable cardiac monitors have facilitated the rapid commercialization of advanced ECG patches. Furthermore, the region's high penetration of remote patient monitoring (RPM) programs—driven by Medicare reimbursement policies and remote care incentives—has accelerated patch adoption in chronic care management. Clinical research institutions and academic medical centers in the US are also increasingly deploying ECG sensor patches in decentralized clinical trials and real-world evidence (RWE) studies, reinforcing consistent demand across provider networks.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=179350490
Prominent players in the ECG sensor patches market are Baxter International Inc. (US), iRhythm Technologies, Inc. (US), Koninklijke Philips N.V. (Netherlands), GE Healthcare Technologies Inc. (US), Boston Scientific Corporation (US), Bittium Corporation (Finland), Biotricity Inc. (US), OSI Systems, Inc. (US), SmartCardia Inc. (Switzerland), and LifeSignals (US).
Koninklijke Philips N.V. (Netherlands):
Koninklijke Philips N.V. (Netherlands) is a global health technology leader, offering advanced solutions in diagnostic imaging, patient monitoring, and health informatics. The company provides ECG sensor patches for remote cardiac monitoring and real-time diagnostics through its Connected Care segment and subsidiary, BioTelemetry, Inc. (US). Koninklijke Philips N.V. (Netherlands) combines clinical expertise with innovative technology to deliver scalable, non-invasive cardiac care across hospitals, clinics, and home settings. With operations in over 100 countries and additional subsidiaries like Respironics Inc. and EPD Solutions Ltd., Koninklijke Philips N.V. (Netherlands) maintains a strong global presence in the digital health ecosystem.
iRhythm Technologies, Inc. (US)
iRhythm Technologies, Inc. (US) is a digital health company specializing in remote cardiac monitoring through wearable biosensing devices and AI-powered analytics. Its Zio platform supports accurate arrhythmia detection and integrates device use, data processing, and clinical reporting for outpatient care. With operations across key international markets, including Japan, Europe, and Southeast Asia, as well as subsidiaries like iRhythm Japan GK and iRhythm Singapore Pte. Ltd., the company is expanding its operations to include access to data-driven cardiac diagnostics.
For more information, Inquire Now!
Related Reports:
Diagnostic Electrocardiograph/ECG Market
Cardiac Monitoring & Cardiac Rhythm Management Devices Market
Patient Monitoring Devices Market
Remote Patient Monitoring Market
Get access to the latest updates on ECG Sensor Patches Companies and ECG Sensor Patches Market Size
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
Share this article